更新关于免疫抑制疗法和移植后肠道微生物群之间的相互干扰
Maurizio Salvadori1, Giuseppina Rosso2
1Department of Renal Transplantation, Careggi University Hospital, Florence 50139, Tuscany, Italy. maurizio.salvadori1@gmail.com.
World journal of transplantation
|April 5, 2024
概括
由于免疫抑制剂,移植患者经历了肠道微生物群的变化,影响药物的有效性和患者的健康. 这种肠道失生症可能导致移植物排斥,感染和腹,影响移植结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 移植显著改变肠道微生物群的组成,特别是在移植后的早期.
- 免疫抑制药物和抗生素是这些微生物转变的主要驱动因素,往往导致失生症.
研究的目的:
- 为了研究免疫抑制药物和移植接受者的肠道微生物群之间的双向关系.
- 了解肠道微生物群的改变如何影响免疫抑制剂的药理动力学和临床结果.
主要方法:
- 关于免疫抑制药物对肠道微生物群的影响现有文献的综述.
- 分析已知的常见免疫抑制剂的微生物转化,如塔克罗利斯和酸.
- 失生症与临床后果的相关性,如移植排斥和感染.
主要成果:
- 免疫抑制剂会改变肠道微生物群,导致失生症,而微生物群可以改变药物代谢.
- 塔克罗利木斯可以被微生物群代谢成一种不那么活跃的形式 (M1).
- 甲酸对甲酸的激活受微生物酶的影响,影响其有效性.
结论:
- 免疫抑制剂和肠道微生物群之间的相互作用对于移植成功至关重要.
- 肠道失生症可能会对移植结果产生负面影响,导致排斥,感染和腹.
- 了解这些相互作用对于优化免疫抑制疗法和移植后患者管理至关重要.
相关概念视频
Cell-mediated Immune Responses
68.2K
Overview
68.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242


